Readings Newsletter
Become a Readings Member to make your shopping experience even easier.
Sign in or sign up for free!
You’re not far away from qualifying for FREE standard shipping within Australia
You’ve qualified for FREE standard shipping within Australia
The cart is loading…
Leukemias and lymphoid diseases as only Williams can cover them
IN FULL COLOR!
Featuring twenty-one chapters originally appearing in Williams Hematology, Ninth Edition - many carefully updated by the original authors to reflect the latest developments – this concise, full-color resource delivers comprehensive and up-to-date coverage of lymphomas and lymphocytic leukemias.
Williams Hematology: Malignant Lymphoid Diseases is more than a sectional reprint: The authors of the twenty-one selected chapters have revised and updated their work in light of three recent developments: an expanded classification of the lymphocytic neoplasm by the World Health Organization, advances in the understanding of biology and genetics of these tumors, and breakthroughs in therapeutic approaches to the lymphomas and lymphocytic leukemias. The result is a focused, timely resource that will benefit clinicians in their research, daily practice, and learning.
$9.00 standard shipping within Australia
FREE standard shipping within Australia for orders over $100.00
Express & International shipping calculated at checkout
Leukemias and lymphoid diseases as only Williams can cover them
IN FULL COLOR!
Featuring twenty-one chapters originally appearing in Williams Hematology, Ninth Edition - many carefully updated by the original authors to reflect the latest developments – this concise, full-color resource delivers comprehensive and up-to-date coverage of lymphomas and lymphocytic leukemias.
Williams Hematology: Malignant Lymphoid Diseases is more than a sectional reprint: The authors of the twenty-one selected chapters have revised and updated their work in light of three recent developments: an expanded classification of the lymphocytic neoplasm by the World Health Organization, advances in the understanding of biology and genetics of these tumors, and breakthroughs in therapeutic approaches to the lymphomas and lymphocytic leukemias. The result is a focused, timely resource that will benefit clinicians in their research, daily practice, and learning.